Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
Clinical trial NCT04987463 · UNKNOWN
Trial details
- NCT number
- NCT04987463
- Sponsor
- Katarzyna Kotulska
- Status
- UNKNOWN
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-07
- Primary completion
- 2026-03-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.